KDM5A and KDM5B induces the growth of cancer cells, reduces the expression of tumor suppressor genes, facilitates the acquired tolerance of cancer-fighting drugs, and maintains tumor-initiating cells [198]. This evidence concerns the gene KDM5A and neoplasm.